RPID - Rapid Micro Biosystems Inc - Ordinary Shares - Class A
IEX Last Trade
0.85
-0.003 -0.306%
Share volume: 20,276
Last Updated: Fri 30 Aug 2024 09:58:28 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$0.85
0.00
-0.31%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-11-10 | 2023-03-10 | 2023-05-09 | 2023-08-04 | 2023-11-03 | 2024-03-01 | 2024-05-03 | 2024-08-02 | |
| Assets | |||||||||
| Total Assets | 201.916 M | 190.650 M | 173.281 M | 160.945 M | 150.164 M | 143.452 M | 127.731 M | 117.085 M | |
| Current Assets | 144.577 M | 138.576 M | 129.145 M | 132.747 M | 115.045 M | 120.415 M | 108.160 M | 98.197 M | |
| Inventories | 20.924 M | 21.187 M | 20.944 M | 20.940 M | 20.193 M | 19.961 M | 20.418 M | 21.429 M | |
| Other Current Assets | 4.101 M | 3.372 M | 3.005 M | 2.278 M | 1.556 M | 2.869 M | 3.285 M | 2.367 M | |
| Short Term Investments | 4.101 M | 3.372 M | 3.005 M | 2.278 M | 1.556 M | 2.869 M | 3.285 M | 2.367 M | |
| Total Receivables | 4.658 M | 5.369 M | 5.510 M | 3.456 M | 3.907 M | 5.532 M | 4.921 M | 5.011 M | |
| Current Cash | 114.894 M | 108.648 M | 99.686 M | 106.073 M | 89.389 M | 92.053 M | 79.536 M | 69.390 M | |
| Total Non-current Assets | 57.339 M | 52.074 M | 44.136 M | 28.198 M | 35.119 M | 23.037 M | 19.571 M | 18.888 M | |
| Property Plant Equipment | 13.230 M | 13.818 M | 13.509 M | 13.126 M | 12.870 M | 12.832 M | 12.615 M | 12.273 M | |
| Other Assets | 8.611 M | 8.182 M | 7.881 M | 7.541 M | 7.345 M | 7.010 M | 6.672 M | 6.331 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 201.916 M | 190.650 M | 173.281 M | 160.945 M | 150.164 M | 143.452 M | 127.731 M | 117.085 M | |
| Total liabilities | 22.900 M | 26.481 M | 20.838 M | 21.317 M | 22.377 M | 25.463 M | 21.788 M | 22.496 M | |
| Total current liabilities | 15.212 M | 19.050 M | 13.660 M | 14.415 M | 15.618 M | 18.986 M | 15.600 M | 16.599 M | |
| Accounts Payable | 3.670 M | 5.428 M | 1.287 M | 1.363 M | 3.271 M | 1.973 M | 1.164 M | 2.180 M | |
| Other liabilities | 221.000 K | 229.000 K | 238.000 K | 247.000 K | 255.000 K | 263.000 K | 272.000 K | 281.000 K | |
| Current long term debt | 747.000 K | 766.000 K | 773.000 K | 802.000 K | 841.000 K | 1.132 M | 1.153 M | 1.173 M | |
| Long term debt | 7.467 M | 7.202 M | 6.940 M | 6.655 M | 6.504 M | 6.214 M | 5.916 M | 5.616 M | |
| Other liabilities | 221.000 K | 229.000 K | 238.000 K | 247.000 K | 255.000 K | 263.000 K | 272.000 K | 281.000 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 179.016 M | 164.169 M | 152.443 M | 139.628 M | 127.787 M | 117.989 M | 105.943 M | 94.589 M | |
| Common stock | 42.518 M | 42.608 M | 42.813 M | 43.060 M | 43.080 M | 43.144 M | 43.246 M | 43.617 M | |
| Retained earnings | -359.471 M | -375.918 M | -389.805 M | -403.821 M | -417.213 M | -428.385 M | -441.707 M | -454.285 M |